» Articles » PMID: 23983766

The Controversial Role of Microglia in Malignant Gliomas

Overview
Date 2013 Aug 29
PMID 23983766
Citations 120
Authors
Affiliations
Soon will be listed here.
Abstract

Malignant gliomas contain stroma and a variety of immune cells including abundant activated microglia/macrophages. Mounting evidence indicates that the glioma microenvironment converts the glioma-associated microglia/macrophages (GAMs) into glioma-supportive, immunosuppressive cells; however, GAMs can retain intrinsic anti-tumor properties. Here, we review and discuss this duality and the potential therapeutic strategies that may inhibit their glioma-supportive and propagating functions.

Citing Articles

Developmental-status-aware transcriptional decomposition establishes a cell state panorama of human cancers.

Luo Y, Liang H Genome Med. 2024; 16(1):124.

PMID: 39468667 PMC: 11514945. DOI: 10.1186/s13073-024-01393-6.


The two-sided battlefield of tumour-associated macrophages in glioblastoma: unravelling their therapeutic potential.

Xiong J, Zhou X, Su L, Jiang L, Ming Z, Pang C Discov Oncol. 2024; 15(1):590.

PMID: 39453528 PMC: 11511804. DOI: 10.1007/s12672-024-01464-5.


Necroptosis-based glioblastoma prognostic subtypes: implications for TME remodeling and therapy response.

Khan M, Huang X, Ye X, Zhang D, Wang B, Xu A Ann Med. 2024; 56(1):2405079.

PMID: 39387496 PMC: 11469424. DOI: 10.1080/07853890.2024.2405079.


Lipid metabolic rewiring in glioma‑associated microglia/macrophages (Review).

Ma Y, Huang Y, Hu F, Shu K Int J Mol Med. 2024; 54(5).

PMID: 39301636 PMC: 11414527. DOI: 10.3892/ijmm.2024.5426.


Phagocytosis Checkpoints in Glioblastoma: CD47 and Beyond.

Afzal A, Afzal Z, Bizink S, Davis A, Makahleh S, Mohamed Y Curr Issues Mol Biol. 2024; 46(8):7795-7811.

PMID: 39194679 PMC: 11352848. DOI: 10.3390/cimb46080462.


References
1.
Fulci G, Breymann L, Gianni D, Kurozomi K, Rhee S, Yu J . Cyclophosphamide enhances glioma virotherapy by inhibiting innate immune responses. Proc Natl Acad Sci U S A. 2006; 103(34):12873-8. PMC: 1568940. DOI: 10.1073/pnas.0605496103. View

2.
Meyers P, Schwartz C, Krailo M, Healey J, Bernstein M, Betcher D . Osteosarcoma: the addition of muramyl tripeptide to chemotherapy improves overall survival--a report from the Children's Oncology Group. J Clin Oncol. 2008; 26(4):633-8. DOI: 10.1200/JCO.2008.14.0095. View

3.
Bao S, Wu Q, McLendon R, Hao Y, Shi Q, Hjelmeland A . Glioma stem cells promote radioresistance by preferential activation of the DNA damage response. Nature. 2006; 444(7120):756-60. DOI: 10.1038/nature05236. View

4.
Kennedy B, Maier L, DAmico R, Mandigo C, Fontana E, Waziri A . Dynamics of central and peripheral immunomodulation in a murine glioma model. BMC Immunol. 2009; 10:11. PMC: 2654428. DOI: 10.1186/1471-2172-10-11. View

5.
Badie B, Schartner J . Flow cytometric characterization of tumor-associated macrophages in experimental gliomas. Neurosurgery. 2000; 46(4):957-61; discussion 961-2. DOI: 10.1097/00006123-200004000-00035. View